Aarti Pharmalabs Limited submitted a regulatory disclosure to the Listing/Compliance Departments of both BSE Limited and the National Stock Exchange of India Limited.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The filing serves as a follow-up to a previous intimation made by the company on May 20, 2026, which concerned an Investors/Analyst Earnings Conference Call. This call was held to discuss the company's Audited Financial Results for the fourth quarter and the full financial year ended March 31, 2026.
The purpose of this current communication is to inform the exchanges that the audio recording of the aforementioned earnings conference call has been uploaded to the company's official website.
The specific URL where the recording can be accessed is: https://www.aartipharmalabs.com/q4-fy-26
The letter was signed by Jeevan Bhargav Mondkar, who holds the positions of Company Secretary and Legal Head. His ICSI membership number is A22565. The document was digitally signed on May 26, 2026, at 22:06:50 IST.